Interleukin-33 as a marker of disease activity in rheumatoid factor positive polyarticular juvenile idiopathic arthritis

Mod Rheumatol. 2017 Jul;27(4):609-613. doi: 10.1080/14397595.2016.1246118. Epub 2016 Oct 27.

Abstract

Objective: To investigate clinical usefulness of serum interleukin (IL)-33 levels as an indicator of disease activity in juvenile idiopathic arthritis (JIA).

Methods: We measured serum levels of IL-33 in 39 patients with JIA, including 7 patients with rheumatoid factor positive poly-JIA (RF + poly-JIA), 8 patients with RF negative poly-JIA (RF-poly-JIA), 20 patients with oligoarticular JIA (Oligo-JIA), 4 patients with enthesitis-related arthritis (ERA) and 30 age-matched healthy controls. Furthermore, we determined their correlation with measures of disease activity.

Results: Serum IL-33 levels in patients with RF + poly-JIA were significantly elevated compared to those in patients with RF-poly-JIA, oligo-JIA and HC. Serum IL-33 levels in patients with RF-poly-JIA, oligo-JIA and ERA were not elevated compared to those in HC. Serum IL-33 levels in RF + poly-JIA patients normalized in remission phase. Serum IL-33 levels correlated positively with RF in patients with RF + poly-JIA.

Conclusions: These results indicate that serum IL-33 levels in RF + poly-JIA patients correlated with disease activity, suggesting a potential role of IL-33 as a promising indicator of disease activity.

Keywords: Interleukin-33; Rheumatoid factor positive polyarticular juvenile idiopathic arthritis.

MeSH terms

  • Adolescent
  • Arthritis, Juvenile / blood*
  • Biomarkers / blood
  • Child
  • Female
  • Humans
  • Interleukin-33 / blood*
  • Male
  • Rheumatoid Factor / blood*

Substances

  • Biomarkers
  • IL33 protein, human
  • Interleukin-33
  • Rheumatoid Factor